Drug Recalls - Prime Therapeutics
See the latest FDA drug recalls
We monitor Food and Drug Administration (FDA) recall notices to keep you in the know.
- Jul. 15 | Sulfamethoxazole / Trimethoprim, 400 mg/80 mg | Amneal
- Jan. 31 | One lot of fentanyl transdermal system 25 mcg/hr | Alvogen
- Dec. 24 | Prograf® (tacrolimus) 0.5 mg and Astagraf XL® (tacrolimus extended-release) 0.5 mg | Astellas
- Dec. 23 | 1 lot of systane lubricant eye drops ultra PF | Alcon
- Dec. 20 | Adrenalin® chloride solution (epinephrine nasal solution, USP) 30 mg/30 mL | Endo
- Nov. 19 | Clonazepam orally disintegrating tablets | Endo
- Sep. 18 | Atovaquone oral suspension 750 mg per 5 mL | Bionpharma
- Sep. 18 | Atovaquone oral suspension 750 mg per 5 mL | Bionpharma
- Jul. 17 | One lot of clonazepam orally disintegrating tablets | Endo
- Jun. 26 | Potassium chloride extended release (ER), 750 mg | American Health Packaging
- Jun. 24 | Potassium chloride extended release (ER), 750 mg | Glenmark
-
Apr. 23 | Sapropterin dihydrochloride 100 mg | Dr. Reddy's
-
Apr. 01 | Atovaquone 750mg/5 mL | Avkare
-
Mar. 27 | Vancomycin hydrochloride for oral solution | Amneal
-
Mar. 12 | Treprostinil Injection 20 mg/20 mL (1 mg/mL) | Par
-
Feb. 26 | Eye ointment products | Brassica
-
Jan. 25 | Zenzedi® (dextroamphetamine sulfate) tablets | Azurity
-
Dec. 18 | Vigabatrin for oral solution | Invagen
-
Nov. 27 | Sandimmune oral solution | Novartis
-
Nov. 24 | Ting® 2% miconazole nitrate athlete’s foot spray | Insight
-
Nov. 21 | Vitrakvi® oral solution 20 mg/mL | Bayer
-
Nov. 17 | Acetaminophen oral suspension | KinderFarms
-
Nov. 15 | Various eye drops | Kilitch Healthcare India
-
Nov. 01 | Rugby brand eye drops supplied by Velocity | The Harvard Drug Group
-
Oct. 03 | Betaxolol | KVK Tech
-
Sep. 28 | BREXAFEMME® (ibrexafungerp tablets) | SCYNEXIS, INC
-
Sep. 22 | Sucralfate oral suspension, 1g_10mL | VistaPharm LLC
-
Sep. 11 | Sandimmune oral solution | Novartis
-
Aug. 31 | Digoxin | Marlex Pharmaceuticals Inc
-
Jul. 31 | Tydemy | Lupin
-
Jul. 07 | Albuterol sulfate | Cipla
-
Jun. 14 | Dronabinol and ziprasidone hydrochloride capsules | The Harvard Drug Group
-
Apr. 26 | Various human drug products | Akorn
-
Mar. 31 | Atovaquone oral suspension | Camber Pharmaceuticals
-
Mar. 03 | Brimonidine tartrate ophthalmic solution | Apotex Corp
-
Feb. 24 | Artificial eye ointment | Global Pharma Healthcare
-
Feb. 02 | Artificial tears lubricant eye drops | Global Pharma
-
Feb. 01 | TIROSINT®-SOL (levothyroxine sodium) oral solution | IBSA Pharma
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online.
- Regular Mail or Fax: Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA0178.
All recalls are being conducted with the knowledge of the United States (U.S.) Food and Drug Administration.
Refer to the United States Food & Drug Administration (FDA) for further information on recalls.
Click here for language services (translation, TTY, etc.).
FDA contact information for reporting adverse events/quality complaints can be reached online or by calling the FDA at 1-888-INFO-FDA (1-888-463-6332) and then selecting prompt #2.
Refer to the United States Food & Drug Administration (FDA) for further information on recalls.
Click here for language services (translation, TTY, etc.).
FDA contact information for reporting adverse events/quality complaints can be reached online or by calling the FDA at 1-888-INFO-FDA (1-888-463-6332) and then selecting prompt #2.